Royal Bank of Canada Lowers Udg Healthcare (LON:UDG) to Sector Performer

Royal Bank of Canada lowered shares of Udg Healthcare (LON:UDG) to a sector performer rating in a research report sent to investors on Monday, Digital Look reports. Royal Bank of Canada currently has GBX 800 ($10.45) target price on the stock, down from their prior target price of GBX 830 ($10.85).

UDG has been the subject of a number of other reports. Numis Securities upgraded shares of Udg Healthcare to a hold rating in a report on Thursday, May 16th. Peel Hunt restated a buy rating on shares of Udg Healthcare in a report on Wednesday, August 7th. Finally, Liberum Capital restated a buy rating on shares of Udg Healthcare in a report on Wednesday, August 7th. Four analysts have rated the stock with a hold rating and three have given a buy rating to the stock. Udg Healthcare has a consensus rating of Hold and an average target price of GBX 799.86 ($10.45).

Shares of LON:UDG opened at GBX 784 ($10.24) on Monday. The stock has a market capitalization of $1.95 billion and a price-to-earnings ratio of 76.12. Udg Healthcare has a 1-year low of GBX 545 ($7.12) and a 1-year high of GBX 819 ($10.70). The company has a debt-to-equity ratio of 26.96, a quick ratio of 1.85 and a current ratio of 1.94. The company has a 50 day moving average price of GBX 781.52 and a 200 day moving average price of GBX 676.85.

About Udg Healthcare

UDG Healthcare plc, together with its subsidiaries, provides advisory, communication, commercial, clinical, and packaging services in the Republic of Ireland, the United Kingdom, North America, and internationally. The company operates in two segments, Ashfield and Sharp. The Ashfield segment offers commercialization services for the pharmaceutical and healthcare industry in the areas of advisory, communications, and commercial and clinical services.

See Also: What is an SEC Filing?

Analyst Recommendations for Udg Healthcare (LON:UDG)

Receive News & Ratings for Udg Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Udg Healthcare and related companies with's FREE daily email newsletter.